Lipodystrophy

Lipodystrophy is a condition where your body doesn't store fat properly. This can lead to losing fat in certain areas, like your arms and legs, while other areas, like your belly, might gain fat. It can be caused by different reasons, including genetics or other health issues.

Condition

What people with Lipodystrophy report

Every report comes from a Lived member, sent anonymously.

Have you had Dermal fillers for Lipodystrophy?

NameHow it went

About Lipodystrophy

What It Is

Lipodystrophy is a group of rare conditions in which the body lacks healthy fat tissue, either almost everywhere (generalized lipodystrophy) or in particular areas such as the arms, legs, hips or face (partial lipodystrophy). It is different from being naturally thin or losing weight through illness or undereating. The fat tissue itself fails to develop or is gradually lost. That matters because fat tissue does more than store energy. It also makes leptin, a hormone that helps signal fullness. When fat tissue is missing, the body struggles to handle the energy from food. Many people develop insulin resistance and diabetes, very high triglycerides (a type of fat in the blood) and fatty liver disease, and these problems can be severe. People with generalized forms often feel intensely hungry because leptin is low. The main types differ in when they start and how serious they are. Congenital generalized lipodystrophy causes a near-complete lack of fat from birth or infancy. Familial partial lipodystrophy usually becomes noticeable around puberty, when fat disappears from the limbs, buttocks and hips while extra fat may collect around the face, neck or abdomen. Acquired forms develop later in someone who was born with normal fat. Lipodystrophy linked to HIV and to injected medicines is managed somewhat differently from these syndromes.

Causes & Risk Factors

Some types are inherited. Congenital generalized lipodystrophy is usually passed on when a child inherits a changed gene from both parents, while familial partial lipodystrophy usually needs only one changed copy, so it often appears in a parent and child. Several different genes can be responsible, and the specific gene can affect which other organs, such as the heart or muscles, may be involved. Acquired generalized and acquired partial lipodystrophy are not inherited. Both are more common in females, usually begin in childhood or adolescence and are often linked to autoimmune conditions, in which the immune system attacks the body's own tissues. In many people, though, no clear trigger is found. In people living with HIV, lipodystrophy has been linked to the virus itself and especially to older HIV medicines. It can mean fat loss from the face and limbs, extra fat in the abdomen, or both. Severe cases have become less common with newer HIV treatments. None of these forms is caused by a person's diet or habits.

How It's Diagnosed

There is no single test for lipodystrophy, and firm diagnostic criteria have not been established. A clinician looks for a lack of fat in a pattern that falls outside normal variation, and asks when it began, whether relatives have similar features and whether childhood photos show normal fat. Other clues include unusually prominent muscles and veins, dark velvety skin patches in body folds (acanthosis nigricans, a sign of insulin resistance) and diabetes or triglyceride problems that seem out of proportion to a person's weight. Two lab findings in particular raise suspicion. One is diabetes that needs very large insulin doses, such as 200 units a day or more. The other is triglycerides of 500 mg/dL or higher, a level well above what clinicians aim for and one that increases the risk of pancreatitis. Blood tests for blood sugar, cholesterol and liver function are part of every assessment. Measuring skinfold thickness, a DEXA scan (dual-energy x-ray absorptiometry, the same type of scan used for bone density) or whole-body MRI can show where fat is missing. Genetic testing can confirm inherited forms and help identify relatives who may be affected, but a negative result does not rule out a genetic cause. Blood tests for complement C3, an immune protein, and for autoantibodies can support a diagnosis of an acquired form. Leptin levels do not establish the diagnosis, although they can help guide treatment. Clinicians also rule out other causes of fat loss, such as uncontrolled diabetes, an overactive thyroid, cancer or an eating disorder. Partial lipodystrophy can be easy to miss, especially in men and when fat loss is gradual, so diagnosis is often delayed.

Treatment Options

There is no cure for lipodystrophy, and no treatment can regrow the missing fat tissue. Treatment aims to control diabetes, triglycerides and fatty liver disease and to prevent the damage they can cause over time. Diet is the foundation. A dietitian usually recommends balanced meals that limit sugar and simple carbohydrates in favor of high-fiber foods, with fats mostly from sources such as olive oil and fish. Cutting calories improves blood sugar and triglycerides in adults, but it can be hard because hunger is often intense. Children need enough food to grow, and overfeeding to reach a typical weight can make metabolic problems worse. Standard medicines for the complications are often needed: metformin and insulin for diabetes (sometimes in very high doses), and statins or fibrates to lower cholesterol and triglycerides. Muscle side effects from these lipid medicines are a particular concern in people who already have muscle disease. Metreleptin (Myalept) is a man-made form of leptin given by injection under the skin. In the United States it is approved, alongside diet, for people with generalized lipodystrophy. It can reduce hunger and lower triglycerides within about a week, with improvements in blood sugar and fatty liver over months, and some young people with the congenital form are able to stop insulin. It is not approved for partial lipodystrophy, where the response tends to be weaker, or for HIV-related lipodystrophy. It is available only through a restricted program because the body can make antibodies that block it, and because lymphoma has been reported in people with acquired generalized lipodystrophy whether or not they used it. Stopping or sharply reducing metreleptin suddenly has led to pancreatitis as triglycerides rebound, so changes should be planned with the prescriber. For adults with HIV and excess abdominal fat, tesamorelin (Egrifta WR), which stimulates the body's own growth hormone, can reduce that fat. It is not a weight-loss drug, and its long-term effects on the heart are not established. Birth control pills and other medicines containing oral estrogen are generally avoided because they can drive triglycerides dangerously high and cause pancreatitis. Progestin-only methods, hormonal intrauterine devices (IUDs) or nonhormonal options are usually preferred, and estrogen through the skin may be used when hormone therapy is needed. For changes in appearance or discomfort, options include facial fillers, fat transfer in some acquired forms, breast implants and removal of excess fat in areas where it builds up.

What to Expect

Lipodystrophy is lifelong, and the lost fat does not come back. How it affects daily life depends heavily on the type. Generalized forms usually bring the most serious metabolic problems and constant attention to food. Familial partial lipodystrophy often causes metabolic trouble mainly from adolescence or adulthood, and acquired partial lipodystrophy usually causes few metabolic problems, although it can affect the kidneys. Regular monitoring is a central part of care. Most people are checked every year for diabetes, cholesterol and triglycerides, liver problems, kidney damage (through a urine protein test) and blood pressure. People with certain genetic types, especially some linked to the LMNA gene, and those with generalized forms may need regular heart tests because heart muscle disease and rhythm problems can occur. People with acquired generalized lipodystrophy should have regular skin and lymph node checks because of their higher lymphoma risk. Women with lipodystrophy commonly have irregular periods, reduced fertility or polycystic ovary syndrome (PCOS). Pregnancy can make diabetes much harder to control, so it is best planned with an obstetrician experienced in diabetes and a specialist familiar with lipodystrophy. Relatives may be offered genetic testing. The physical changes can be distressing, and missing fat pads in the feet or buttocks can make standing or sitting uncomfortable. Support from a mental health professional or a patient community can help. Because the condition is rare, care is often coordinated by an endocrinologist with experience in lipodystrophy.

When to Seek Help

Ask for an evaluation if you notice unexplained fat loss from your limbs, face or whole body, or if diabetes or high triglycerides are unusually hard to control despite treatment. Talk to your care team before starting any hormonal birth control or hormone therapy, and before a planned pregnancy. If you take metreleptin, contact your prescriber if you develop a serious infection or if your blood sugar or triglycerides start worsening, since this can mean the medicine is losing its effect. Severe pain in the upper abdomen, which may spread to the back and often comes with nausea or vomiting, can be a sign of pancreatitis from very high triglycerides and needs medical care right away.

Questions to Ask Your Doctor

  1. 1.Which type of lipodystrophy do I have, and would genetic testing change my care or matter for my relatives?
  2. 2.Which complications am I most at risk for, and which tests should I have each year?
  3. 3.Am I a candidate for metreleptin or another treatment, and what improvements would be realistic?
  4. 4.What eating pattern makes sense for me, and can you refer me to a dietitian who knows this condition?
  5. 5.Which birth control or hormone options are safe for me, and how should I plan for a pregnancy?

Last reviewed • Oct 2026

Educational content, not medical advice.